Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Crossflo Acquires Vigilys Platform

I am very pleased to see yet another piece added toward the completion of my expectations puzzle. RG is executing things just as he stated. I eagerly look forward to more announcements, and a commensurate increase in revenue from our new ventures. Until then, the market will continue to watch us with a cautious eye, though I do not expect that to remain the case forever.

Good luck to us all.

Cheers,

DG

Share
New Message
Please login to post a reply